Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce its participation as a premier regenerative medicine company at Innovations in Wound ...
Across three high-intensity days - Friday, Saturday, and Sunday - Hemostemix will meet with clinicians, researchers, and innovators to highlight the significant outcomes following treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback